{"transactions":[{"id":3787332,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":162902,"kind":"person","name":"Jones Randal","position":1,"cik":"0001723453","reported_name":"Jones Randal","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-18T21:10:22.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":1270,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.2,"exercise_date":"2017-12-31","expiration_date":"2018-08-15","underlying":"Common Stock","underlying_shares":1270},"source":{"system":"sec-edgar","filing":"0001567619-18-004305","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000156761918004305/doc1.xml","form_type":"4"}},{"id":3787331,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":162902,"kind":"person","name":"Jones Randal","position":1,"cik":"0001723453","reported_name":"Jones Randal","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-18T21:10:22.000Z","date":"2018-08-13","kind":"sale","acquired":false,"shares":1270,"price":3.98,"value":5054.6,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-004305","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000156761918004305/doc1.xml","form_type":"4"}},{"id":3787330,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":162902,"kind":"person","name":"Jones Randal","position":1,"cik":"0001723453","reported_name":"Jones Randal","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-18T21:10:22.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":1270,"price":3.2,"value":4064.0,"ownership":{"direct":true},"balance_after":1270,"source":{"system":"sec-edgar","filing":"0001567619-18-004305","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000156761918004305/doc1.xml","form_type":"4"}},{"id":3878394,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":162902,"kind":"person","name":"Jones Randal","position":1,"cik":"0001723453","reported_name":"Jones Randal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-02T21:27:37.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":1012,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1012,"derivative":{"exercise_price":4.34,"exercise_date":"2018-06-29","expiration_date":"2028-06-29","underlying":"Common Stock","underlying_shares":1012},"source":{"system":"sec-edgar","filing":"0001562180-18-003169","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000156218018003169/primarydocument.xml","form_type":"4"}},{"id":3969084,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":162902,"kind":"person","name":"Jones Randal","position":1,"cik":"0001723453","reported_name":"Jones Randal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-04T18:34:26.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":2056,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2056,"derivative":{"exercise_price":4.29,"exercise_date":"2018-03-31","expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":2056},"source":{"system":"sec-edgar","filing":"0001562180-18-001828","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000156218018001828/primarydocument.xml","form_type":"4"}},{"id":4106689,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":162902,"kind":"person","name":"Jones Randal","position":1,"cik":"0001723453","reported_name":"Jones Randal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-04T15:14:48.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":1270,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1270,"derivative":{"exercise_price":3.2,"exercise_date":"2017-12-31","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":1270},"source":{"system":"sec-edgar","filing":"0001562180-18-000176","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000156218018000176/primarydocument.xml","form_type":"4"}},{"id":4153966,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":162902,"kind":"person","name":"Jones Randal","position":1,"cik":"0001723453","reported_name":"Jones Randal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-21T21:04:15.000Z","date":"2017-11-17","kind":"grant","acquired":true,"shares":16714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grant shall vest one-third on each of the first, second and third anniversaries of the date of grant, provided Mr. Jones is then a director of the Company."}],"balance_after":16714,"derivative":{"exercise_price":1.13,"expiration_date":"2027-11-17","underlying":"Common Stock","underlying_shares":16714},"source":{"system":"sec-edgar","filing":"0001104659-17-069923","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000110465917069923/a4.xml","form_type":"4"}}]}